(1)-13-Ethyl-17alpha-hydroxy-18,19-dinor-pregn-4-en-20-yn-3-one oxime acetate
[(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
Also Known As: NORGESTIMATE|Norgestimatum|Norgestimato|Ortho-Cyclen|Norgestimate CRS|Dexnorgestrel acetime|RefChem:203767|Norgestimatum [INN-Latin]|Norgestimato [INN-Spanish]|C291HFX4DY|CTK8G2000|EINECS 244-046-1|HSDB 7898|KIQQMECNKUGGKA-GOMYTPFNSA-N|HMS3715E17|Norgestimate [USAN:USP:INN:BAN]|ORF 10131|RWJ 10131|Norgestimate for system suitability CRS|D 138|(1)-13-Ethyl-17alpha-hydroxy-18,19-dinor-pregn-4-en-20-yn-3-one oxime acetate|17beta-acetoxy-13beta-ethyl-17alpha-ethynyl-gon-4-en-3-one oxime|18,19-Dinor-17alpha-pregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, acetate (ester), (+-)|d-13-beta-Ethyl-17-alpha-ethynyl-17-beta-acetoxygon-4-en-3-one oxime|(17-alpha)-17-(Acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime|18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17-alpha)-|(+)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester)|(1R,3aS,3bR,9aR,9bS,11aS)-11a-Ethyl-1-ethynyl-7-(hydroxyimino)-2,3,3a,3b,4,5,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-cyclopenta[a]phenanthren-1-yl acetate|18,19-Dinor-17-pregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, oxime, (17alpha)- (+)-|18,19-Dinor-17-pregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, oxime, (17alpha)-(+)-|Norgestimate; (3EZ)-13ss-Ethyl-3-(hydroxyimino)-18,19-dinor-17a-pregn-4-en-20-yn-17-yl acetate; 18,19-Dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (17a)-; D 138; Dexnorgestrel acetime; Norgestimate; ORF 10131; RWJ 10131; d-(17a)-17-Acetoxy-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one oxime
| Molecular Formula | C23H31NO3 |
|---|---|
| Molecular Weight | 369.2304 g/mol |
| LogP | 4.71 |
| Topological Polar Surface Area | 58.89 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Exact Mass | 369.2304 |
| Heavy Atoms | 27 |
| Complexity | 732.4 |
Chemical Identifiers
| CAS Number | 35189-28-7 |
|---|---|
| SMILES | CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=CC(=NO)CC[C@H]34 |
Product Overview
(1)-13-Ethyl-17alpha-hydroxy-18,19-dinor-pregn-4-en-20-yn-3-one oxime acetate (CAS 35189-28-7), with molecular formula C23H31NO3 and molecular weight 369.2304 g/mol. IUPAC: [(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate.
Frequently Asked Questions
📚 Academic Support
Scientific research papers and technical documentation supporting this product for informed procurement decisions.
Technical Blog Article
Multi-source research profile: chemical properties, regulatory status, and sourcing guide for (1)-13-Ethyl-17alpha-hydroxy-18,19-dinor-pregn-4-en-20-yn-3-one oxime acetate.
Browse Technical Blog →No research papers found for this product yet.
We continuously update our academic references. Check back soon!